Sildenafil versus Papaverine in the diagnosis of male erectile dysfunctio
Not Applicable
- Conditions
- Health Condition 1: null- Erectile DysfunctionHealth Condition 2: N529- Male erectile dysfunction, unspecified
- Registration Number
- CTRI/2015/08/006096
- Lead Sponsor
- niversity College of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1 All patients aged greater than or equal to 18 years giving informed consent to participate in the study.
2 At least a 3 months prior history of erectile dysfunction.
3 International Index of Erectile Function-5 (IIEF-5)13 scores <21.
Exclusion Criteria
1. Patients not willing for consent for inclusion in the above study.
2. Patients on Sildenafil citrate therapy within last two weeks.
3.Patients with known contraindications for PDE5-Is such as poor cardiac performance, severe ischemia, coagulation defects, recent myocardial infarction and patients on nitrate therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method